Tulosta

Statiinilääkitys monisairailla ja iäkkäillä

Lisätietoa aiheesta
18.12.2017
Hannu Vanhanen

Monisairaat, statiinihoito ja lääkeinteraktiot

Iäkkäät ja statiinihoito

Kirjallisuutta

  1. Athyros VG, Tziomalos K, Gossios TD ym. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010;376:1916-22 «PMID: 21109302»PubMed
  2. Musso G, Cassader M, Gambino R. Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update. Curr Opin Lipidol 2011;22:489-96 «PMID: 21986643»PubMed
  3. Corsini A, Ceska R. Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel? Curr Med Res Opin 2011;27:1551-62 «PMID: 21682551»PubMed
  4. Rowan C, Brinker AD, Nourjah P ym. Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors. Pharmacoepidemiol Drug Saf 2009;18:301-9 «PMID: 19206087»PubMed
  5. U.S. Food and Drug Administration. FDA Drug Safety Podcast for Healthcare Professionals: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury. http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm258399.htm (accessed 6/21/2011)
  6. U.S. Food and Drug Administration. FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury. Available at http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm (accessed 6/27/2011)
  7. Rosengren A. Better treatment and improved prognosis in elderly patients with AMI: but do registers tell the whole truth? Eur Heart J 2012;33:562-3 «PMID: 22285577»PubMed
  8. Gale CP, Cattle BA, Woolston A ym. Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010. Eur Heart J 2012;33:630-9 «PMID: 22009446»PubMed
  9. Aronow WS. Management of hyperlipidemia with statins in the older patient. Clin Interv Aging 2006;1:433-8 «PMID: 18046920»PubMed
  10. Cholesterol Treatment Trialists’ (CTT) Collaboration., Baigent C, Blackwell L ym. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-81 «PMID: 21067804»PubMed
  11. Glynn RJ, Koenig W, Nordestgaard BG ym. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med 2010;152:488-96, W174 «PMID: 20404379»PubMed
  12. Shepherd J, Blauw GJ, Murphy MB ym. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623-30 «PMID: 12457784»PubMed
  13. Han BH, Sutin D, Williamson JD ym. Effect of Statin Treatment vs. Usual Care on Primary Cardiovascular Prevention Among Older AdultsThe ALLHAT-LLT Randomized Clinical Trial
  14. Deedwania P, Stone PH, Bairey Merz CN ym. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation 2007;115:700-7 «PMID: 17283260»PubMed
  15. Strandberg T. Sydän- ja verisuonisairauksien ehkäisy yli 80-vuotiailla. Duodecim 2008;124:1801-3
  16. Tilvis R. Vanheneminen muuttaa riskitekijöitä ja niiden painoarvoa. Duodecim 2010;126:2220-1
Käypä hoito -suositukset ovat riippumattomia, tutkimusnäyttöön perustuvia kansallisia hoitosuosituksia. Lue lisää
KÄYPÄ HOITO -SUOSITUS Dyslipidemiat
LINKKIEN TYYPIT JA VÄRIKOODIT
Kirjallisuusviite
Kuva
Linkki toiselle sivustolle
Lisätietoa
Näytönastekatsaus
PDF-tiedosto
PubMed-abstrakti
Taulukko